More articles about: Rogel Cancer Center

green pink close up on microscope
Health Lab

New mouse model for liposarcoma can help uncover new therapies

There has been little progress in understanding and treating liposarcoma due to its rarity and lack of research resources. In a new study, University of Michigan researchers have developed a novel mouse model that mirrors the disease in humans.
Zhen Xu, Ph.D.
News Release

Xu named among Time magazine’s most influential in health

U-M Health Rogel Cancer Center research member Zhen Xu, Ph.D., was selected to Time magazine’s TIME100 Health.
man on white bed in blue pajamas with iv pole behind him neutral expression on face
Health Lab

2 multiple myeloma treatments receive FDA approval

The Food and Drug Administration approved two drugs—daratumumab and linvoseltamab—for precursor conditions to multiple myeloma and relapsed multiple myeloma. Matthew Pianko answers questions about the current treatment options for multiple myeloma, the new FDA-approved drugs and what these treatments mean for patients.
Members of the Shenandoah Young Adult Committee and others stand in front of a yellow and blue balloon arch in front of the Shenandoah Country Club.
Philanthropy News

Shenandoah Country Club sets the pace for faith-based philanthropy

The Shenandoah Country Club's inaugural 5k run and walk raised vital funds for people facing cancer at the U-M Rogel Cancer Center.
The illustration depicts a brain with a glioma and its digital twin.
Health Lab

Brain cancer digital twin predicts treatment outcomes

A machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the University of Michigan, could help doctors discover which treatment strategies are most likely to be effective against individual cases of glioma.
lungs in blue and yellow spots floating
Health Lab

'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

University of Michigan researchers found a new protein target PP2A and developed a drug to treat non-small cell lung cancers that have KRAS mutations.
two researchers posing white coats looking at camera
Health Lab

Leukemia drug secures FDA approval

Komzifti (ziftomenib), developed at Michigan Medicine, has been approved for patients with acute myeloid leukemia caused by the NPM1 gene mutation.
Cancer Aware surrounded by a circle of multicolor ribbons
Cancer Aware

Understanding Prostate Biopsy

Those with an elevated prostate-specific antigen test are referred for a biopsy of their prostate to help diagnose prostate cancer or other prostate concerns. This can bring anxiety and discomfort for the patient.
normal pancreas drawing and one labeled PDAC
Health Lab

Gut microbiome may influence how patients with pancreatic cancer respond to treatment

Microbes create unique communities called microbiomes in the gut, oral cavity, skin and urogenital regions. Donnele Daley discusses common misconceptions about “healthy” microbes, the role of microbiomes in pancreatic cancer and future research directions.
women smiling with each other for camera
Health Lab

Doctors treat lung cancer patient after cancer metastasized to her brain

Linda Rossi was initially diagnosed with lung cancer and moved to Michigan for treatment from U-M. She received surgery, but four years later the tumor spread to her brain, and she was treated with surgery and radiation.
Susan and Richard Rogel stand with Dr. Eric Fearon the director of the Rogel Cancer Center as well as the leaders of the new Rogel and Blondy Center for Pancreatic Cancer Research
News Release

Ribbon-cutting for new pancreatic cancer program

The Rogel and Blondy Center for Pancreatic Cancer was officially launched with a special ribbon-cutting ceremony on the sixth floor of the Rogel Cancer Center.
puzzle looking string of orange with lab gloves blue
Health Lab

Capturing cancer cells from blood could help doctors choose the right breast cancer treatment

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood, study from the University of Michigan and the University of Kansas suggests.
Rogel Cancer Center through trees
News Release

Rogel Cancer Center names Christopher Liekweg associate director for administration

The University of Michigan Rogel Cancer Center has named Christopher J. Liekweg, M.B.A., CMPE, associate director for administration and chief department administrator. Liekweg is a senior administrator at VCU Health, the academic medical center of Virginia
Rogel Cancer Center building during the day
News Release

Rogel Cancer Center adds 3 new senior leadership roles

The University of Michigan Rogel Cancer has named two new deputy directors and a new associate director to provide strategic leadership in cancer care, research and training: Michael Deininger, M.D., Ph.D.; Lesly Dossett, M.D., M.P.H.; and Samuel Kaffenberger, M.D.
close up device
Health Lab

At-home melanoma testing: Skin patch test works in mice

Melanoma testing could one day be done at home with a skin patch and test strip with two lines, similar to COVID-19 home tests, according to University of Michigan researchers.